YanWei Li

6PUBLICATIONS
1CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2026
YBX1 Promotes Malignant Progression of HNSCC via Stabilizing NSUN2-m5C Modified ATF4 mRNA.

|Mar 15, 2025
Aumolertinib plus chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 19 deletion or exon 21 L858R: a phase II trial.

Yanwei Li, Chenguang Li, Xiaoliang Zhao

|Oct 08, 2024
Efficacy and safety of camrelizumab-based comprehensive treatment for non-small cell lung cancer: a systematic review and meta-analysis.

Nuerbiyamu Maimaitiyiming, Yue Li, Yunfeng Cao

|Sep 05, 2022
Systematic Analysis of Molecular Subtypes and Immune Prediction Based on CD8 T Cell Pattern Genes Based on Head and Neck Cancer.

Li Yanwei, Feng He, Shuang Liu

|Aug 10, 2022
Traditional Chinese medicine formula 01 for nasopharyngeal carcinoma (NPC01) for head & neck cancer and health-related quality of life: a retrospective study.

Li Yanwei, He Feng, Wang Xudong

|Jan 24, 2022
Apatinib and Ginsenoside-Rb1 Synergetically Control the Growth of Hypopharyngeal Carcinoma Cells.

YanWei Li, Feng He, Yu Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Feng He